PARTICLE THERAPY MARKET ANALYSIS

Particle Therapy MarketSize and Trends

Particle therapy is a form of external beam radiotherapy that is used in the treatment of various types of cancers such as prostate cancer, brain, tumors near the spine, pediatric cancer, gastrointestinal cancer, and melanoma of the eye. Moreover, for the treatment of cancer, a beam of energetic neutrons, protons or other heavier positive ion particles are used at the target tumors. These particles damage the tissue of DNA cell.

Particle therapy is considered as safer and effective than the conventional radiation therapy, as particle therapy can deliver high dose to the specific area without affecting the surrounding tissue areas.

Market Trends:

The increasing prevalence of various types of cancers is a major factor driving the growth of the global particle therapy market. For instance, in 2018, according to the World Health Organization (WHO), cancer was the second leading cause of death and accounted for 9.6 million (about one in six deaths were due to cancer) deaths, globally. In addition, colorectal, stomach, lung, prostate, and liver cancer are common in men while breast, colorectal, lung, and thyroid cancer are common in women.

The increasing adoption of inorganic growth strategies such as collaboration by key players is another factor fueling growth of the global particle therapy market. For instance, in 2017, Royal Philips and Proton Partners International collaborated with Ion Beam Application (IBA). The main objective of the collaboration was to establish first compact proton therapy system in the Middle East. Hence, these factors are expected to drive the global particle therapy market growth over the forecast period.